Results 51 to 60 of about 8,939 (172)

The epidemiological and clinical association between primary focal hyperhidrosis and various skin disease in Japanese patients: outpatient questionnaire analysis

Journal of Cutaneous Immunology and Allergy
Hyperhidrosis, defined as excessive sweating beyond physiological needs. It impairs the quality of life (QOL) of patients. While there are many studies on the relationship between sweating and skin diseases, however few studies have been conducted from ...
Keiji Kosaka, Akihiko Uchiyama, Mai Ishikawa, Sei-Ichiro Motegi   +3 more
doaj   +1 more source

A retrospective review on minimally invasive technique via endoscopic thoracic sympathectomy (ETS) in the treatment of severe primary hyperhidrosis: Experiences from the National Heart Institute, Malaysia [version 1; peer review: 2 approved]

F1000Research, 2018
Background: Hyperhidrosis is due to the hyperactive autonomic stimulation of the sweat glands in response to stress. Primary hyperhidrosis is a common yet psychologically disabling condition.
Ahmad Farouk Musa, Vignaa Prashanth Gandhi, Jeswant Dillon, Rusli Bin Nordin   +3 more
doaj   +1 more source

Unilateral Upper Limb Lymphedema After Microwave Thermolysis Treatment for Axillary Hyperhidrosis

JEADV Clinical Practice, Volume 5, Issue 1, Page 219-221, March 2026.
ABSTRACT Microwave thermolysis (MiraDry) is an approved, nonsurgical treatment for axillary hyperhidrosis. We report a case of unilateral lymphedema of the upper limb in a 45‐year‐old male patient treated for axillary hyperhidrosis with the MiraDry device.
Emanuela Micu, Natalja Jacobsson
wiley   +1 more source

Safety and efficacy of zuranolone in Japanese adults with major depressive disorder: An open‐label, repeated‐treatment part of a Phase 3 clinical trial

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 1, March 2026.
Abstract Aim To evaluate the safety and tolerability of repeating 14‐day treatment with zuranolone (30 mg) followed by a 6‐week follow‐up period (one treatment cycle) for a maximum of six treatment cycles in Japanese participants with major depressive disorder. Methods This multicenter Phase 3 study was conducted in two parts (70 sites; Japan).
Masaki Kato, Kazuyuki Nakagome, Takamichi Baba, Takuhiro Sonoyama, Hiroki Fukuju, Ryosuke Shimizu, Juan Carlos Gomez, Tomoko Motomiya, Takeshi Inoue   +8 more
wiley   +1 more source

“No Words for Feelings”: Alexithymia in Children With Cystic Fibrosis and Their Caregivers

Pediatric Pulmonology, Volume 61, Issue 3, March 2026.
ABSTRACT Aim Children with cystic fibrosis (CF) face significant physical and psychological challenges due to their chronic condition, which may affect emotional regulation and sleep quality. Alexithymia, characterized by difficulties in identifying and expressing emotions, has been linked to psychological distress and poor health outcomes in chronic ...
Tuğba Şişmanlar Eyüboğlu, Ayşe Tana Aslan, Zeynep İlkşen Hocoğlu, Pelin Asfuroğlu, Eylül Pınar Çakir, Azime Şebnem Soysal Acar, Volkan Medeni   +6 more
wiley   +1 more source

Comparative study of transepidermal water loss in patients with and without hyperhidrosis by closed-chamber measurer in an air-conditioned environment

Einstein (São Paulo)
Objective To evaluate the difference in transepidermal water loss in patients diagnosed with hyperhidrosis and healthy subjects, in an air-conditioned environment.
Andre Miotto, Pedro Augusto Antunes Honda, Thiago Gangi Bachichi, Caio Santos Holanda, Ernesto Evangelista Neto, João Alessio Juliano Perfeito, Luiz Eduardo Villaça Leão, Altair da Silva Costa Jr   +7 more
doaj   +1 more source

Injection‐site and dermatologic reactions associated with glucagon‐like peptide‐1 receptor agonists: Insights from meta‐analysis of randomised controlled trials and real‐world evidence

Diabetes, Obesity and Metabolism, Volume 28, Issue 3, Page 1956-1971, March 2026.
Abstract Aims Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are widely used for type 2 diabetes mellitus and obesity, with once‐weekly dosing that supports adherence. However, injection‐site reactions (ISRs) and dermatologic events have been recognised, ranging from mild local events to rare systemic hypersensitivity reactions that may cause ...
Shifa Taj, Mohammed Zuber, Muhammed Rashid, Manik Chhabra, Krishna Undela, Smita Rawal, Lorenzo Villa Zapata   +6 more
wiley   +1 more source

Decreased work productivity due to primary palmar hyperhidrosis. What is the cost?

Skin Health and Disease, 2021
J. K. Kristensen, C. Nielsen
doaj   +1 more source

Role of video-assisted thoracoscopic sympathectomy in the treatment of primary hyperhidrosis

São Paulo Medical Journal
CONTEXT: Essential hyperhidrosis is a frequent disorder causing significant functional impairment. The advent and development of video-assisted thoracoscopic techniques now allows thoracic sympathectomy to be carried out precisely and safety with good ...
Luiz Eduardo Villaça Leão, Renato de Oliveira, Renuzza Szulc, Jair de Jesus Mari, Pedro Luis Reis Crotti, José Julio Saraiva Gonçalves   +5 more
doaj   +1 more source

Efficacy and safety of switching basal insulin to insulin glargine 300 U/mL in individuals with inadequately controlled type 2 diabetes on advanced insulin therapies: The Toujeo‐Neo T2DM study

Diabetes, Obesity and Metabolism, Volume 28, Issue 3, Page 2237-2244, March 2026.
Abstract Aims This real‐world study evaluated the effectiveness and safety of switching basal insulin (BI) to insulin glargine 300 U/mL (Gla‐300) in adults with inadequately controlled type 2 diabetes mellitus (T2DM), previously receiving basal‐supported oral therapy plus prandial insulin (BOTplus) or multiple (≥3) daily injections (MDI) of short ...
Stefan Pscherer, Andreas Fritsche, Helmut Anderten, Katrin Pegelow, Henry Y. Han, Martin Pfohl, Jochen Seufert   +6 more
wiley   +1 more source